Saturday, November 9, 2024
- Advertisement -spot_img

TAG

KBio

KBio Announces FDA Clearance of IND Application for EV68-228-N for the Treatment of Acute Flaccid Myelitis and the First Patient Dosed in the Phase...

• The United States Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for EV68-228-N, a human monoclonal IgG1 against...

Latest news

- Advertisement -spot_img